FDAnews Announces — Understanding CSV User Requirements: Save Time and Money by Getting it Right from the Start Webinar, June 24, 2015
Falls Church, VA (PRWEB) June 09, 2015 -- Understanding CSV User Requirements:
Save Time and Money by Getting it Right from the Start
**FDAnews Webinar**
June 24, 2015 — 1:30 p.m. – 3:00 p.m. EDT
http://www.fdanews.com/CSVUserReqs
For a process supported by a computer system, Computer System Validation (CSV) provides documented proof that the system (hardware, software, peripherals and/or network) will repeatedly and reliably do what it is designed to do, is “fit-for-purpose,” and complies with applicable rules and regulations. Regulators will not take the manufacturers word for it — there must be formal evidence.
The ultimate goal of any CSV project is to realize and sustain compliance, while ensuring the peak performance and functionality of those systems; it is a sound business practice that supports Q/A and promotes responsible, profitable operations.
The most important element of a CSV
Without a doubt, the User Requirements Specifications (URS) is the most critical document in CSV. User requirements should be the starting point of any project. A properly structured and referenced URS will ensure that user requirements are properly specified, remain traceable and are documented.
All too often companies do not actually spend the required time to develop the user requirements; instead, they rush, and the project suffers as a result. In fact, at least 50% of the time should be spent developing solid user requirements.
Poorly written user requirements can lead to costly delays in validation further down the line, as well as FDA action.
Join Gaurav Walia, a leading CSV expert, on June 24, 2015, as he shows the most fundamental steps and common pitfalls for writing URS. In 90 minutes attendees will learn:
• The 3 levels of URS and when they are needed
o Installation qualification
o Operational qualification
o Functionality qualification
• How to properly write a URS — one that is clear, concise and testable
• How to prioritize an URS with emphasis on identifying mandatory requirements
• What requirements an URS should contain — ones that are specific and appropriate for the desired system
• Who should be involved in writing a URS
• How to classify requirements so that appropriate focus is given to the critical ones
• And much more…
Meet the Presenter:
Mr. Gaurav Walia, M.S. has over 17 years of pharmaceutical experience with careers at Monsanto/Searle, Pfizer/Oread, Forest Laboratories, and others while also serving as a pharmaceutical consultant in various disciplines from Quality Systems, R&D, CD, CSV, Vendor Certification, etc. Mr. Walia has managed various technical, quality and compliance groups, such as but not limited to, Pharma R&D, Laboratory Information Management Systems (LIMS), Metrology, Quality Control (QC), Materials Import and Export, Safety, New Facility Design, Validation and Commissioning, Capital Budget (Instrument and Equipment Acquisition from R&D to Commercial, Operating Budget (All Service contracts), Regulatory Compliance, etc.
Who Will Benefit:
• Data Management and Statistical Personnel
• Engineering and Design Control Teams
• Executive Management
• QA/QC Personnel
• Validation Specialists/Scientist/Engineers
Conference Details:
Understanding CSV User Requirements:
Save Time and Money by Getting it Right from the Start
**FDAnews Webinar**
June 24, 2015 — 1:30 p.m. – 3:00 p.m. EDT
http://www.fdanews.com/CSVUserReqs
Tuition:
$287 per site
Easy Ways to Register:
Online: http://www.fdanews.com/CSVUserReqs
By phone: 888-838-5578 or 703-538-7600
About FDAnews:
FDAnews is the premier provider of domestic and international regulatory, legislative, and business news and information for executives in industries regulated by the US FDA and the European Medicines Agency. Pharmaceutical and medical device professionals rely on FDAnews' print and electronic newsletters, books and conferences to stay in compliance with international standards and the FDA's complex and ever-changing regulations.
Michelle Butler, FDANEWS, http://www.fdanews.com, +1 (703) 538-7665, [email protected]
Share this article